The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
Open accessAbstract
N-acetylcysteine (NAC), which is an acetylated cysteine compound, has aroused scientific interest for decades due to its important medical applications. It also represents a nutritional supplement in the human diet. NAC is a glutathione precursor and shows antioxidant and anti-inflammatory activities. In addition to the uses quoted in the literature, NAC may be considered helpful in therapies to counteract neurodegenerative and mental health diseases. Furthermore, this compound has been evaluated for its neuroprotective potential in the prevention of cognitive aging dementia. NAC is inexpensive, commercially available and no relevant side effects were observed after its administration. The purpose of this paper is to give an overview on the effects and applications of NAC in Parkinson’s and Alzheimer’s disorders and in neuropathic pain and stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · cited 1×
“Three classes of glutamate-gated channels are known and a group of G-proteins associated with glutamate receptors induce the mobilization of Ca2+ from internal reserves [38,39].”
BackgroundPHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J.-P. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,081
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126 · cited 1×
“Furthermore, around 40–60% of people may achieve a partial relief, which represents a pain difficult to treat [116].”
BackgroundColloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,058
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650 · cited 1×
“The Aβ may be observed in various forms such as in soluble, aggregated, oligomeric, protofibrillar, and fibrillary [90,91].”
BackgroundGiasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & -Y. Lee, V. M. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,546
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
The glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,325
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
NMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
The chemistry and biological activities of N-acetylcysteine
Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876
Role of Distinct NMDA Receptor Subtypes at Central Synapses
Cull-Candy, S. G., & Leszkiewicz, D. N. (2004) · Science's STKE · doi:10.1126/stke.2552004re16 · Cited by 804
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse
Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X.-C., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 739
Richman, P. G., & Meister, A. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41830-9 · Cited by 730
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & McQuay, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub2 · Cited by 690
The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate
Baker, D. A., Xi, Z.-X., Shen, H., Swanson, C. J., & Kalivas, P. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09134.2002 · Cited by 584
Bridges, R. J., Natale, N. R., & Patel, S. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01480.x · Cited by 538
Molecular Mechanisms of Glutamate Receptor-Mediated Excitotoxic Neuronal Cell Death
Sattler, R., & Tymianski, M. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:107 · Cited by 537
Molecular mechanisms of L-DOPA-induced dyskinesia
Jenner, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2471 · Cited by 523
The importance of neuritic plaques and tangles to the development and evolution of AD
Tiraboschi, P., Hansen, L. A., Thal, L. J., & Corey-Bloom, J. (2004) · Neurology · doi:10.1212/01.wnl.0000129697.01779.0a · Cited by 477
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein
Selkoe, D. J. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3111 · Cited by 466
Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Farr, S. A., Poon, H. F., Dogrukol‐Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., & Morley, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01580.x · Cited by 459
Molecular basis of NMDA receptor functional diversity
Paoletti, P. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07628.x · Cited by 451
The promise of N-acetylcysteine in neuropsychiatry
Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434 · cited 1×
“This activity of NAC may be attributed to its curative action, considering the crucial role of glutamate signaling in neuropsychiatric diseases [47,48].”
BackgroundMeister, A. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)51106-7 · Cited by 428
Moran, M. M., McFarland, K., Melendez, R. I., Kalivas, P. W., & Seamans, J. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1007-05.2005 · Cited by 411
N‐acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
Bavarsad Shahripour, R., Harrigan, M. R., & Alexandrov, A. V. (2014) · Brain and Behavior · doi:10.1002/brb3.208 · Cited by 410
Kantrowitz, J. T., & Javitt, D. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.006 · Cited by 396
Role of membrane transport in metabolism and function of glutathione in mammals
Bannai, S., & Tateishi, N. (1986) · The Journal of Membrane Biology · doi:10.1007/bf01870891 · Cited by 383
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371
Drake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371
Clinical Pharmacokinetics of N-Acetylcysteine
Holdiness, M. R. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199120020-00004 · Cited by 359
Talley, A. K., Dewhurst, S., Perry, S. W., Dollard, S. C., Gummuluru, S., Fine, S. M., New, D., Epstein, L. G., Gendelman, H. E., & Gelbard, H. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2359 · Cited by 302
Butterfield, D. A., Bader Lange, M. L., & Sultana, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.02.005 · Cited by 299
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Moore, R. A., Wiffen, P. J., Derry, S., & Rice, A. S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub3 · Cited by 292
Pyruvate Released by Astrocytes Protects Neurons from Copper-Catalyzed Cysteine Neurotoxicity
Wang, X. F., & Cynader, M. S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03322.2001 · Cited by 285
Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis
Etminan, M., Gill, S. S., & Samii, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70097-1 · Cited by 279
The systemic availability of oral glutathione
Witschi, A., Reddy, S., Stofer, B., & Lauterburg, B. H. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02284971 · Cited by 273
Estus, S., Tucker, H. M., van Rooyen, C., Wright, S., Brigham, E. F., Wogulis, M., & Rydel, R. E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07736.1997 · Cited by 258
Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity
Jha, N., Jurma, O., Lalli, G., Liu, Y., Pettus, E. H., Greenamyre, J. T., Liu, R.-M., Forman, H. J., & Andersen, J. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000120200 · Cited by 252
Offen, D., Ziv, I., Sternin, H., Melamed, E., & Hochman, A. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0136 · Cited by 250
Oxidative damage in mild cognitive impairment and early Alzheimer's disease
Lovell, M. A., & Markesbery, W. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21346 · Cited by 245
Lee, M., Cho, T., Jantaratnotai, N., Wang, Y. T., McGeer, E., & McGeer, P. L. (2010) · The FASEB Journal · doi:10.1096/fj.09-149997 · Cited by 243
Khan, M., Sekhon, B., Jatana, M., Giri, S., Gilg, A. G., Sekhon, C., Singh, I., & Singh, A. K. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20087 · Cited by 236
Inflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders
Schwab, C., & McGeer, P. L. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13402 · Cited by 234
N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases
Holmay, M. J., Terpstra, M., Coles, L. D., Mishra, U., Ahlskog, M., Öz, G., Cloyd, J. C., & Tuite, P. J. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31829ae713 · Cited by 216 · cited 1×
“The treatment with NAC has shown an increase in blood GSH redox ratios in patients-treated and healthy controls, which was followed by an increase in brain GSH levels in all nine participants and no adverse events were observed [143].”
Nutritional biochemistry of cellular glutathione
Sen, C. K. (1997) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(97)00113-7 · Cited by 212
Glutamatergic medications for the treatment of drug and behavioral addictions
Olive, M. F., Cleva, R. M., Kalivas, P. W., & Malcolm, R. J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.015 · Cited by 210
N-acetylcysteine and neurodegenerative diseases: Basic and clinical pharmacology
Arakawa, M., & Ito, Y. (2007) · The Cerebellum · doi:10.1080/14734220601142878 · Cited by 206
Naik, A. K., Tandan, S. K., Dudhgaonkar, S. P., Jadhav, S. H., Kataria, M., Prakash, V. R., & Kumar, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.08.006 · Cited by 193
Metabotropic receptors for glutamate and GABA in pain
Goudet, C., Magnaghi, V., Landry, M., Nagy, F., Gereau, R. W., & Pin, J.-P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.007 · Cited by 188
The role of glutathione in radiation and drug induced cytotoxicity.
Mitchell, J. B., & Russo, A. (1987) · Europe PMC (PubMed Central) · Cited by 187
N‐Acetylcysteine suppresses TNF‐induced NF‐κB activation through inhibition of IκB kinases
Oka, S.-I., Kamata, H., Kamata, K., Yagisawa, H., & Hirata, H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01464-2 · Cited by 186
Mitochondrial Dysfunction in Aging and Alzheimer's Disease: Strategies to Protect Neurons
Reddy, P. H. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1754 · Cited by 186
Sha, D., Chin, L.-S., & Li, L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp501 · Cited by 184
Pocernich, C. B., Cardin, A. L., Racine, C. L., Lauderback, C. M., & Allan Butterfield, D. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00012-2 · Cited by 183
Stroke intervention pathways: NMDA receptors and beyond
Lai, T. W., Shyu, W.-C., & Wang, Y. T. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.12.008 · Cited by 178
Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.014 · Cited by 173
Reduced intravenous glutathione in the treatment of early parkinson's disease
Sechi, G., Deledda, M. G., Bua, G., Satta, W. M., Deiana, G. A., Pes, G. M., & Rosati, G. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00103-0 · Cited by 173
Cocco, T., Sgobbo, P., Clemente, M. T., Lopriore, B., Grattagliano, I., Paola, M. D., & Villani, G. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.034 · Cited by 173
Coles, L. D., Tuite, P. J., Öz, G., Mishra, U. R., Kartha, R. V., Sullivan, K. M., Cloyd, J. C., & Terpstra, M. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1008 · Cited by 170
Pocernich, C. B., La Fontaine, M., & Butterfield, D. A. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00126-6 · Cited by 165
Prevention of PC12 Cell Death by N-Acetylcysteine Requires Activation of the Ras Pathway
Yan, C. Y. I., & Greene, L. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-11-04042.1998 · Cited by 162
Pahan, K., Sheikh, F. G., Namboodiri, A. M. S., & Singh, I. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00137-8 · Cited by 161
Maintenance of glutathione content is isolated hepatocyctes
Viña, J., Hems, R., & Krebs, H. A. (1978) · Biochemical Journal · doi:10.1042/bj1700627 · Cited by 160
N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia
Sekhon, B., Sekhon, C., Khan, M., Patel, S. J., Singh, I., & Singh, A. K. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02244-3 · Cited by 159
Fuller, S. L., Steele, M. L., & Münch, G. W. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.08.016 · Cited by 158
Varney, M. A., & Gereau, R. W. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339300 · Cited by 156
Monti, D., Zabrecky, G. P., Kremens, D. E., Liang, T., Wintering, N., Cai, J., Wei, X., Bazzan, A. J., Li, Z., Bowen, B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157602 · Cited by 152
Fu, A., Dong, Z., & Sun, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.042 · Cited by 151
Remington, R., Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y. M., Smyers, K., Page, R., Morrell, C. H., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142499 · Cited by 141
N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects
Minarini, A., Ferrari, S., Galletti, M., Giambalvo, N., Perrone, D., Rioli, G., & Galeazzi, G. M. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1251580 · Cited by 137
Nutritional Approaches to Modulate Oxidative Stress in Alzheimers Disease
Pocernich, C. B., Lange, M. L. B., Rukhsana Sultana, A., & Butterfield, D. A. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391908 · Cited by 130
Walsh, D. M., Hartley, D. M., Condron, M. M., Selkoe, D. J., & Teplow, D. B. (2001) · Biochemical Journal · doi:10.1042/bj3550869 · Cited by 128
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Agid, Y., Ruberg, M., Javoy-Agid, F., Hirsch, É. C., Raisman‐Vozari, R., Vyas, S., Faucheux, B. A., Michel, P. P., Kästner, A., & Blanchard, V. (1993) · PubMed · Cited by 127
Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in α-Synuclein Overexpressing Mice
Clark, J., Clore, E. L., Zheng, K., Adame, A., Masliah, E., & Simon, D. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012333 · Cited by 125
Hsu, M., Bharath, S., Kumar, J., Rajagopalan, S., & Andersen, J. K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02929.x · Cited by 115
Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine
Baker, D. L., Madayag, A., Kristiansen, L. V., Meador‐Woodruff, J. H., Haroutunian, V. H., & Raju, I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301532 · Cited by 115
Arima, K. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00669.x · Cited by 115
Antioxidant approaches for the treatment of Alzheimer’s disease
Lee, H. P., Zhu, X., Casadesús, G., Castellani, R. J., Nunomura, A., Smith, M. A., Lee, H., & Perry, G. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.74 · Cited by 113
do Nascimento, M. M., Suliman, M. E., Silva, M., Chinaglia, T., Marchioro, J. C., Hayashi, S. Y., RIELLA, M. C., Lindholm, B., & Anderstam, B. (2010) · Peritoneal Dialysis International · doi:10.3747/pdi.2009.00073 · Cited by 113
Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases
Banaclocha, M. M. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1194 · Cited by 105
N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence
Ooi, S. L., Green, R., & Pak, S. C. (2018) · BioMed Research International · doi:10.1155/2018/2469486 · Cited by 105
Sjödin, K., Nilsson, E., Hallberg, A., & Tunek, A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90677-1 · Cited by 103
Genetic and environmental risk factors in Parkinson’s disease
Veldman, B. A. J., Wijn, A. M., Knoers, N. V. A. M., Praamstra, P., & Horstink, M. W. I. M. (1998) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(98)00009-2 · Cited by 103
Fawzi, N. L., Okabe, Y., Yap, E.-H., & Head-Gordon, T. L. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.011 · Cited by 97
Paintlia, M. K., Paintlia, A. S., Contreras, M. A., Singh, I., & Singh, A. K. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.011 · Cited by 93
Nishio, N., Taniguchi, W., Sugimura, Y. K., Takiguchi, N., Yamanaka, M., Kiyoyuki, Y., Yamada, H., Miyazaki, N., Yoshida, M., & Nakatsuka, T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.023 · Cited by 92
Huang, Q., Aluise, C. D., Gururaj Joshi, A., Rukhsana Sultana, A., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22422 · Cited by 91
Acetylcholine esterase activity in mild cognitive impairment and Alzheimer’s disease
Herholz, K. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0699-4 · Cited by 87
N -Acetylcysteine Enhances Hippocampal Neuronal Survival After Transient Forebrain Ischemia in Rats
Knuckey, N. W., Palm, D. E., Primiano, M. J., Epstein, M. H., & Johanson, C. E. (1995) · Stroke · doi:10.1161/01.str.26.2.305 · Cited by 86
Varga, V., Jenei, Z., Janáky, R., Saransaari, P., & Oja, S. S. (1997) · Neurochemical Research · doi:10.1023/a:1027377605054 · Cited by 81
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
Fitzmaurice, P. S., Ang, L. C., Guttman, M., Rajput, A. H., Furukawa, Y., & Kish, S. J. (2003) · Movement Disorders · doi:10.1002/mds.10486 · Cited by 81
Martínez, M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02005-9 · Cited by 79
Remington, R., Bechtel, C., Larsen, D., Samar, A., Page, R., Morrell, C., & Shea, T. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151098 · Cited by 79
Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents
Lahiri, D. K., Rogers, J. T., Greig, N. H., & Sambamurti, K. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383331 · Cited by 76
N-acetyl-L-cysteine inhibits 26S proteasome function: implications for effects on NF-κB activation
Pajonk, F., Riess, K., Sommer, A., & McBride, W. H. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00743-8 · Cited by 76
Chiechio, S., Copani, A., Zammataro, M., Battaglia, G., Gereau, R. W., & Nicoletti, F. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.12.003 · Cited by 76
The functional neurophysiology of the amyloid precursor protein (APP) processing pathway
Randall, A. D., Witton, J., Booth, C., Hynes-Allen, A. M., & Brown, J. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.011 · Cited by 76
N-Acetylcysteine delays age-associated memory impairment in mice: role in synaptic mitochondria
Martínez, M., Hernández, A. I., & Martínez-Banaclocha, N. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02349-5 · Cited by 73
N-acetyl-cysteine attenuates neuropathic pain by suppressing matrix metalloproteinases
Li, J., Xu, L., Deng, X., Jiang, C., Pan, C., Chen, L., Han, Y., Dai, W., Hu, L., Zhang, G., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000575 · Cited by 72
Molecular Mechanisms of l-DOPA-Induced Dyskinesia
Fisone, G., & Bézard, E. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00004-3 · Cited by 71
Hypoxia-inducible factor 1 contributes to N-acetylcysteine’s protection in stroke
Zhang, Z., Yan, J., Taheri, S., Liu, K. J., & Shi, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.007 · Cited by 71
Aoki, E., Yano, R., Yokoyama, H., Kato, H., & Araki, T. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.10.004 · Cited by 68
Hypothesis: Can N-acetylcysteine be beneficial in Parkinson's disease?
Martínez, M., Martínez, N., Hernández, A. I., & Ferrándiz, M. L. (1999) · Life Sciences · doi:10.1016/s0024-3205(98)00472-x · Cited by 67
Hara, Y., Fillit, H. M., Dacks, P. A., & McKeehan, N. (2017) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2017.22 · Cited by 66
Neuwelt, E. A., Pagel, M. A., Hasler, B. P., DeLoughery, T. G., & Muldoon, L. L. (2001) · PubMed · Cited by 65
Dose dependent pharmacokinetics of N‐ACETYLCYSTEINE AFTER ORAL DOSING TO MAN
Borgström, L., & Kågedal, B. (1990) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510110205 · Cited by 65
Age-related increase in oxidized proteins in mouse synaptic mitochondria
Martínez, M., Hernández, A. I., Martínez-Banaclocha, N., & Ferrándiz, M. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00708-1 · Cited by 62
Martínez, M., Hernández, A. I., Martínez-Banaclocha, N., & Ferrándiz, M. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00493-9 · Cited by 61
Medina, S., Martínez, M., & Hernánz, Á. (2002) · Free Radical Research · doi:10.1080/107157602100006445 · Cited by 61
Gilbert, K. R., Aizenman, E., & Reynolds, I. J. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90045-u · Cited by 57
Koppal, T., Drake, J., & Butterfield, D. A. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00014-9 · Cited by 52
Bernabucci, M., Notartomaso, S., Zappulla, C., Fazio, F., Cannella, M., Motolese, M., Battaglia, G., Bruno, V., Gradini, R., & Nicoletti, F. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-77 · Cited by 52
Sözbir, E., & Nazıroğlu, M. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9769-7 · Cited by 50
Stahl, S. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1101 · Cited by 47
Bagh, M. B., Maiti, A. K., Jana, S., Banerjee, K., Roy, A., & Chakrabarti, S. (2008) · Free Radical Research · doi:10.1080/10715760802158430 · Cited by 47
Guttman, M., Slaughter, P. M., Thériault, M. E., DeBoer, D. P., & Naylor, C. D. (2001) · Neurology · doi:10.1212/wnl.57.12.2278 · Cited by 45
Xu, Y., Hou, X., Liu, Y. U., & Zong, Y. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21909 · Cited by 44
Liu, Y., Liu, W.-C., Sun, Y., Shen, X., Wang, X., Shu, H., Pan, R., Liu, C., Liu, W., Liu, K. J., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9932-0 · Cited by 39
Role of glutathione and other endogenous thiols in radiation protection
Mitchell, J. B., Biaglow, J. E., & Russo, A. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90072-1 · Cited by 37
Emet, S., Memiş, D., & Pamukçu, Z. (2004) · Critical Care · doi:10.1186/cc2866 · Cited by 34
Wang, B., Aw, T. Y., & Stokes, K. Y. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.038 · Cited by 31
N-Acetylcysteine elicited increase in cytochrome c oxidase activity in mice synaptic mitochondria
Martı́nez, M., & Martínez-Banaclocha, N. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01819-3 · Cited by 30
Studer, R. O., Baysang, G., & Brack, C. (2001) · Biogerontology · doi:10.1023/a:1010065103073 · Cited by 28
da Costa, M. D., Bernardi, J. S., Costa, L., Fiuza, T., Brandão, R., Ribeiro, M. F., Amaral, J. D., Rodrigues, C., & Pereira, M. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.008 · Cited by 27
Smith, L., Tracy, D. K., & Giaroli, G. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000431 · Cited by 26
Hsiao, Y., Chen, P. S., Yeh, S.-H., Lin, C., & Gean, P. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21710 · Cited by 25
Effects of N-acetylcysteine on spinal cord oxidative stress biomarkers in rats with neuropathic pain
Horst, A., de Souza, J. A., Santos, M. C. Q., Riffel, A. P. K., Kolberg, C., & Partata, W. A. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176533 · Cited by 22
Ishige, K., Tanaka, M., Arakawa, M., Saito, H., & Ito, Y. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.07.010 · Cited by 18
Tsai, W., Tsai, R., Liu, C., Wu, J., & Wong, C. (2015) · Journal of Orthopaedic Research® · doi:10.1002/jor.23069 · Cited by 13
Integrated Regulation of Signal Coding and Plasticity by NMDA Receptors at a Central Synapse
D'Angelo, E. U., & Rossi, P. (1998) · Neural Plasticity · doi:10.1155/np.1998.8 · Cited by 13
Horst, A., de Souza, J. A., Santos, M. C. Q., Riffel, A. P. K., Kolberg, C., Ribeiro, M. F. M., de Fraga, L. S., & Partata, W. A. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20165801 · Cited by 8
Cited by
An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases
Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115938 · Cited by 1,085
N-Acetylcysteine (NAC): Impacts on Human Health
Tenório, M. C. D. S., Graciliano, N. G., Moura, F. A., Oliveira, A. C. M. D., & Goulart, M. O. F. (2021) · Antioxidants · doi:10.3390/antiox10060967 · Cited by 526
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Raghu, G., Berk, M., Campochiaro, P. A., Jaeschke, H., Marenzi, G., Richeldi, L., Wen, F.-Q., Nicoletti, F., & Calverley, P. M. A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666201230144109 · Cited by 280
Glutathione and glutathione-dependent enzymes: From biochemistry to gerontology and successful aging
Lapenna, D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102066 · Cited by 239
Metadata
- Authors
- Tardiolo, G., Bramanti, P., & Mazzon, E.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-12-13
- Volume
- 23
- Issue
- 12
- Pages
- 3305
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2904968162
- Cited by
- 285
- References
- 143
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.